Advertisement

Collagen Vascular Diseases and Disorders of Connective Tissue

  • Kelly J. Butnor
  • Andras Khoor

Abstract

The collagen vascular diseases, also referred to as connective tissue diseases, are a diverse group of systemic inflammatory disorders thought to be immunologically mediated. The concept of collagen vascular disease began to take shape in the 1930s, when it was recognized that rheumatic fever and rheumatoid arthritis can affect connective tissues throughout the body.1,2 During the following decade, as conditions such as systemic lupus erythematosus (SLE) and scleroderma came to be viewed as systemic diseases of connective tissue, the terms diffuse connective disease and diffuse collagen disease were proposed.3,4 During the same period, the designation of diffuse vascular disease was proposed for diseases such as scleroderma, polymyositis, SLE, and polyarteritis nodosa, which featured widespread vascular involvement.5 With the realization that many of these entities can exhibit both systemic connective tissue manifestations and vascular abnormalities, the unifying designation of collagen vascular disease was introduced.6

Keywords

Systemic Lupus Erythematosus Ankylose Spondylitis Systemic Lupus Erythematosus Patient Primary Biliary Cirrhosis Interstitial Lung Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klinge F. Der Rheumatismus. Pathologisch-anatomische und experimentell-pathologische tatsachen und ihre auswertung fur das anztliche rheumaproblem. Ergeb Allg Pathol 1933;27:1–351.Google Scholar
  2. 2.
    Klinge F. Zur pathologischen anatomie des rhematismus. Verh Dtsch Orthop Ges 1934;28:44–50.Google Scholar
  3. 3.
    Klemperer P, Pollack AD, Baehr G. Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma. JAMA 1942;119:331–332.CrossRefGoogle Scholar
  4. 4.
    Klemperer P. The concept of collagen diseases. Am J Pathol 1950;26:505–519.PubMedGoogle Scholar
  5. 5.
    Banks BM. Is there a common denominator in scleroderma, dermatomyositis, disseminated lupus erythematosus, the Libman-Sack’s syndrome and polyarteritis nodosa? N Z Med J 1941;225:433–444.CrossRefGoogle Scholar
  6. 6.
    Rich AR. Hypersensitivity in disease, with special reference to periarteritis nodosa, rheumatic fever, disseminated lupus erythematosus and rheumatoid arthritis. Harvey Lect 1947;42:106–147.Google Scholar
  7. 7.
    Black L, Katz S. Respiratory disease: task force report on problems, research approaches, needs. Bethesda, MD: National Hearth and Lung Institute, 1977.Google Scholar
  8. 8.
    Tanaka N, Newell JD, Brown KK, et al. Collagen vascular disease-related lung disease: high-resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 2004;28:351–360.PubMedCrossRefGoogle Scholar
  9. 9.
    Boulware DW, Weissman DN, Doll NJ. Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy 1985;3:249–267.PubMedCrossRefGoogle Scholar
  10. 10.
    Lynch JP 3rd, Hunninghake GW. Pulmonary complications of collagen vascular disease. Annu Rev Med 1992;43:17–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Nozawa Y. Histopathological findings of the lung in collagen diseases—especially on their differential diagnosis. Acta Pathol Jpn 1972;22:843–858.PubMedGoogle Scholar
  12. 12.
    Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989;10:677–722.PubMedGoogle Scholar
  13. 13.
    Homma Y, Ohtsuka Y, Tanimura K, et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 1995;62:248–251.PubMedCrossRefGoogle Scholar
  14. 14.
    Nagao T, Nagai S, Kitaichi M, et al. Usual interstitial pneumonia: idiopathic pulmonary fibrosis versus collagen vascular diseases. Respiration 2001;68:151–159.PubMedCrossRefGoogle Scholar
  15. 15.
    Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581–1586.PubMedCrossRefGoogle Scholar
  16. 16.
    Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167:1410–1415.PubMedCrossRefGoogle Scholar
  17. 17.
    Agusti C, Xaubet A, Roca J, et al. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax 1992;47:1035–1040.PubMedCrossRefGoogle Scholar
  18. 18.
    Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727–733.PubMedCrossRefGoogle Scholar
  19. 19.
    Hakala M, Paakko P, Huhti E, et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990;9:452–460.PubMedCrossRefGoogle Scholar
  20. 20.
    Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770–777.PubMedGoogle Scholar
  21. 21.
    Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706–713.PubMedCrossRefGoogle Scholar
  22. 22.
    Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585–596.PubMedCrossRefGoogle Scholar
  23. 23.
    Kitaichi M, Nagai S, Ito I, et al. Pulmonary pathology in association with connective tissue disorders. Curr Diag Pathol 2004;10:291–303.CrossRefGoogle Scholar
  24. 24.
    Nakamura Y, Chida K, Suda T, et al. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:235–241.PubMedGoogle Scholar
  25. 25.
    Fujita J, Yoshinouchi T, Ohtsuki Y, et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001;60:281–283.PubMedCrossRefGoogle Scholar
  26. 26.
    Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:121–127.PubMedGoogle Scholar
  27. 27.
    Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182–1185.PubMedCrossRefGoogle Scholar
  28. 28.
    Travis WD, Matsui K, Moss J, et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Wall CP, Gaensler EA, Carrington CB, et al. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981;123:280–285.PubMedGoogle Scholar
  30. 30.
    Nagata N, Hirano H, Takayama K, et al. Step section preparation of transbronchial lung biopsy. Significance in the diagnosis of diffuse lung disease. Chest 1991;100:959–962.PubMedCrossRefGoogle Scholar
  31. 31.
    Meduri GU, Stover DE, Greeno RA, et al. Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections. Chest 1991;100:1272–1276.PubMedCrossRefGoogle Scholar
  32. 32.
    Stoller JK, Rankin JA, Reynolds HY The impact of bronchoalveolar lavage cell analysis on clinicians’ diagnostic reasoning about interstitial lung disease. Chest 1987;92:839–843.PubMedCrossRefGoogle Scholar
  33. 33.
    American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277–304.CrossRefGoogle Scholar
  34. 34.
    Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980;30:411–426.PubMedCrossRefGoogle Scholar
  35. 35.
    Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985;72:1155–1162.PubMedCrossRefGoogle Scholar
  36. 36.
    Ellman P, Cudkowicz L. Pulmonary manifestations in the diffuse collagen diseases. Thorax 1954;9:46–57.PubMedCrossRefGoogle Scholar
  37. 37.
    Massumi RA, Legier JF. Rheumatic pneumonitis. Circulation 1966;33:417–425.PubMedCrossRefGoogle Scholar
  38. 38.
    Tandon HD, Kasturi J. Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J 1975;37:26–36.PubMedCrossRefGoogle Scholar
  39. 39.
    Chopra P, Bhatia ML. Chronic rheumatic heart disease in India: a reappraisal of pathologic changes. J Heart Valve Dis 1992;1:92–101.PubMedGoogle Scholar
  40. 40.
    Garrod A. A treatise on gout and rheumatic gout. London: Longman Green, 1876.Google Scholar
  41. 41.
    Petty TL, Wilkins M. The five manifestations of rheumatoid lung. Dis Chest 1966;49:75–82.PubMedCrossRefGoogle Scholar
  42. 42.
    Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979;119:471–503.PubMedGoogle Scholar
  43. 43.
    Cruickshank B. Interstitial pneumonia and its consequences in rheumatoid disease. Br J Dis Chest 1959;53:226–236.PubMedCrossRefGoogle Scholar
  44. 44.
    Anaya JM, Diethelm L, Ortiz LA, et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995;24:242–254.PubMedCrossRefGoogle Scholar
  45. 45.
    Carmona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897–900.PubMedCrossRefGoogle Scholar
  46. 46.
    Turesson C, O’Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62–67.PubMedGoogle Scholar
  47. 47.
    Geddes DM, Corrin B, Brewerton DA, et al. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 1977;46:427–444.PubMedGoogle Scholar
  48. 48.
    Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA 1979;242:528–532.PubMedCrossRefGoogle Scholar
  49. 49.
    Penny WJ, Knight RK, Rees AM, et al. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 1982;41:469–472.PubMedCrossRefGoogle Scholar
  50. 50.
    Hayakawa H, Sato A, Imokawa S, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1531–1536.PubMedCrossRefGoogle Scholar
  51. 51.
    Schlesinger C, Meyer CA, Veeraraghavan S, et al. Constrictive (obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature. Ann Diagn Pathol 1998;2:321–334.PubMedCrossRefGoogle Scholar
  52. 52.
    Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol 1985;16:700–706.PubMedCrossRefGoogle Scholar
  53. 53.
    Kinoshita M, Higashi T, Tanaka C, et al. Follicular bronchiolitis associated with rheumatoid arthritis. Intern Med 1992;31:674–677.PubMedCrossRefGoogle Scholar
  54. 54.
    Wells AU, du Bois RM. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655–666.PubMedGoogle Scholar
  55. 55.
    Sato A, Hayakawa H, Uchiyama H, et al. Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1903–1907.PubMedCrossRefGoogle Scholar
  56. 56.
    Howling SJ, Hansell DM, Wells AU, et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999;212:637–642.PubMedGoogle Scholar
  57. 57.
    Remy-Jardin M, Remy J, Cortet B, et al. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994;193:375–382.PubMedGoogle Scholar
  58. 58.
    Hillarby MC, McMahon MJ, Grennan DM, et al. HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 1993;32:794–797.PubMedCrossRefGoogle Scholar
  59. 59.
    Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 1999;23:941–948.PubMedCrossRefGoogle Scholar
  60. 60.
    Shadick NA, Fanta CH, Weinblatt ME, et al. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994;73:161–170.PubMedCrossRefGoogle Scholar
  61. 61.
    Bonafede RP, Benatar SR. Bronchocentric granulomatosis and rheumatoid arthritis. Br J Dis Chest 1987;81:197–201.PubMedCrossRefGoogle Scholar
  62. 62.
    Hellems SO, Kanner RE, Renzetti AD Jr. Bronchocentric granulomatosis associated with rheumatoid arthritis. Chest 1983;83:831–832.PubMedCrossRefGoogle Scholar
  63. 63.
    Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996;2:429–433.PubMedCrossRefGoogle Scholar
  64. 64.
    Travis WD, Colby TV, Koss MN, et al. Connective tissue and inflammatory bowel diseases. In: Non-neoplastic disorders of the lower respiratory tract. First series. Washington, DC: American Registry of Pathology and the Armed Forces Institute of Pathology, 2002:312.Google Scholar
  65. 65.
    Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112–1125.PubMedCrossRefGoogle Scholar
  66. 66.
    Schwarz MI, Zamora MR, Hodges TN, et al. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998;113:1609–1615.PubMedCrossRefGoogle Scholar
  67. 67.
    Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528–535.PubMedCrossRefGoogle Scholar
  68. 68.
    Roschmann RA, Rothenberg RJ. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum 1987;16:174–185.PubMedCrossRefGoogle Scholar
  69. 69.
    Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004;232:81–91.PubMedCrossRefGoogle Scholar
  70. 70.
    Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136–147.PubMedCrossRefGoogle Scholar
  71. 71.
    Fujita J, Yamadori I, Suemitsu I, et al. Clinical features of non-specific interstitial pneumonia. Respir Med 1999;93:113–118.PubMedCrossRefGoogle Scholar
  72. 72.
    Ippolito JA, Palmer L, Spector S, et al. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Semin Arthritis Rheum 1993;23:70–78.PubMedCrossRefGoogle Scholar
  73. 73.
    Pommepuy I, Farny M, Billey T, et al. Bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis. Rev Rhum Engl Ed 1998;65:65–67.PubMedGoogle Scholar
  74. 74.
    Rees JH, Woodhead MA, Sheppard MN, et al. Rheumatoid arthritis and cryptogenic organising pneumonitis. Respir Med 1991;85:243–246.PubMedCrossRefGoogle Scholar
  75. 75.
    Strimlan CV, Rosenow EC 3rd, Weiland LH, et al. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978;88:616–621.PubMedCrossRefGoogle Scholar
  76. 76.
    Fujii M, Adachi S, Shimizu T, et al. Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thorac Imaging 1993;8:54–62.PubMedGoogle Scholar
  77. 77.
    McDonagh J, Greaves M, Wright AR, et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118–122.PubMedCrossRefGoogle Scholar
  78. 78.
    Pratt DS, Schwartz MI, May JJ, et al. Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax 1979;34:587–593.PubMedCrossRefGoogle Scholar
  79. 79.
    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-2001. A 77-year-old man with rheumatoid arthritis and acute dyspnea and renal failure. N Engl J Med 2001;345:1193–1200.CrossRefGoogle Scholar
  80. 80.
    Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987;135:26–34.PubMedGoogle Scholar
  81. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987;135:250–263.PubMedGoogle Scholar
  82. 82.
    Garcia JG, James HL, Zinkgraf S, et al. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis 1987;136:811–817.PubMedCrossRefGoogle Scholar
  83. 83.
    Macfarlane JD, Dieppe PA, Rigden BG, et al. Pulmonary and pleural lesions in rheumatoid disease. Br J Dis Chest 1978;72:288–300.PubMedCrossRefGoogle Scholar
  84. 84.
    Yousefzadeh DK, Fishman PA. The triad of pneumonitis, pleuritis, and pericarditis in juvenile rheumatoid arthritis. Pediatr Radiol 1979;8:147–150.PubMedCrossRefGoogle Scholar
  85. 85.
    Athreya BH, Doughty RA, Bookspan M, et al. Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review. Clin Chest Med 1980;1:361–374.PubMedGoogle Scholar
  86. 86.
    Fukuoka J, Leslie KO. Chronic diffuse lung diseases. In: Leslie KO, Wick MR, eds. Practical pulmonary pathology: a diagnostic approach. Philadelphia: Churchill Livingstone, 2005:181–258.Google Scholar
  87. 87.
    Duthie JJ, Brown PE, Truelove LH, et al. Course and prognosis in rheumatoid arthritis. A further report. Ann Rheum Dis 1964;23:193–204.PubMedCrossRefGoogle Scholar
  88. 88.
    Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med 1973;54:445–452.PubMedCrossRefGoogle Scholar
  89. 89.
    Benedek TG. Subcutaneous nodules and the differentiation of rheumatoid arthritis from rheumatic fever. Semin Arthritis Rheum 1984;13:305–321.PubMedCrossRefGoogle Scholar
  90. 90.
    Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968;47:501–520.PubMedCrossRefGoogle Scholar
  91. 91.
    Scadding JG. The lungs in rheumatoid arthritis. Proc R Soc Med 1969;62:227–238.PubMedGoogle Scholar
  92. 92.
    Jurik AG, Davidsen D, Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol 1982;11:217–224.PubMedCrossRefGoogle Scholar
  93. 93.
    Eraut D, Evans J, Caplin M. Pulmonary necrobiotic nodules without rheumatoid arthritis. Br J Dis Chest 1978;72:301–306.PubMedCrossRefGoogle Scholar
  94. 94.
    Hull S, Mathews JA. Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis 1982;41:21–24.PubMedCrossRefGoogle Scholar
  95. 95.
    Nusslein HG, Rodl W, Giedel J, et al. Multiple peripheral pulmonary nodules preceding rheumatoid arthritis. Rheumatol Int 1987;7:89–91.PubMedCrossRefGoogle Scholar
  96. 96.
    Beumer HM, van Belle CJ. Pulmonary nodules in rheumatoid arthritis. Respiration 1972;29:556–564.PubMedCrossRefGoogle Scholar
  97. 97.
    Kaye BR, Kaye RL, Bobrove A. Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am J Med 1984;76:279–292.PubMedCrossRefGoogle Scholar
  98. 98.
    Burrows FG. Pulmonary nodules in rheumatoid disease: a report of two cases. Br J Radiol 1967;40:256–261.PubMedCrossRefGoogle Scholar
  99. 99.
    Johnson TS, White P, Weiss ST, et al. Endobronchial necrobiotic nodule antedating rheumatoid arthritis. Chest 1982;82:199–200.PubMedCrossRefGoogle Scholar
  100. 100.
    Jolles H, Moseley PL, Peterson MW. Nodular pulmonary opacities in patients with rheumatoid arthritis. A diagnostic dilemma. Chest 1989;96:1022–1025.PubMedCrossRefGoogle Scholar
  101. 101.
    Baruch AC, Steinbronn K, Sobonya R. Pulmonary adenocarcinomas associated with rheumatoid nodules: a case report and review of the literature. Arch Pathol Lab Med 2005;129:104–106.PubMedGoogle Scholar
  102. 102.
    Shiel WC Jr, Prete PE. Pleuropulmonary manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1984;13:235–243.PubMedCrossRefGoogle Scholar
  103. 103.
    Ellman P, Cudkowicz L, Elwood JS. Widespread serous membrane involvement by rheumatoid nodules. J Clin Pathol 1954;7:239–244.PubMedCrossRefGoogle Scholar
  104. 104.
    Walters MN, Ojeda VJ. Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients. Med J Aust 1986;144:648–651.PubMedGoogle Scholar
  105. 105.
    Ziff M. The rheumatoid nodule. Arthritis Rheum 1990;33:761–767.PubMedCrossRefGoogle Scholar
  106. 106.
    Filho JS, Soares MF, Wal R, et al. Fine-needle aspiration cytology of pulmonary rheumatoid nodule: case report and review of the major cytologic features. Diagn Cytopathol 2002;26:150–153.PubMedCrossRefGoogle Scholar
  107. 107.
    Ramirez J, Campbell GD. Rheumatoid disease of the lung with cavitation. Report of two cases. Dis Chest 1966;50:544–547.PubMedCrossRefGoogle Scholar
  108. 108.
    Stengel BF, Watson RR, Darling RJ. Pulmonary rheumatoid nodule with cavitation and chronic lipid effusion. JAMA 1966;198:1263–1266.PubMedCrossRefGoogle Scholar
  109. 109.
    Yates DA. Cavitation of a rheumatoid lung nodule. Ann Phys Med 1963;201:105–106.Google Scholar
  110. 110.
    Yue CC, Park CH, Kushner I. Apical fibrocavitary lesions of the lung in rheumatoid arthritis. Report of two cases and review of the literature. Am J Med 1986;81:741–746.PubMedCrossRefGoogle Scholar
  111. 111.
    Crisp AJ, Armstrong RD, Grahame R, et al. Rheumatoid lung disease, pneumothorax, and eosinophilia. Ann Rheum Dis 1982;41:137–140.PubMedCrossRefGoogle Scholar
  112. 112.
    Chauhan MS, Tewari SC, Prakash MJ, et al. Necrobiotic pulmonary nodule leading to pyopneumothorax in a case of rheumatoid arthritis—a rare clinical presentation. Indian J Chest Dis Allied Sci 1989;31:217–220.PubMedGoogle Scholar
  113. 113.
    McConnochie K, O’Sullivan M, Khalil JF, et al. Aspergillus colonization of pulmonary rheumatoid nodule. Respir Med 1989;83:157–160.PubMedCrossRefGoogle Scholar
  114. 114.
    Cavazza A, Paci M, Turrini E, et al. Fungus colonisation of pulmonary rheumatoid nodule. J Clin Pathol 2003;56:636–637.PubMedCrossRefGoogle Scholar
  115. 115.
    Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953;8:29–37.PubMedCrossRefGoogle Scholar
  116. 116.
    Caplan A, Payne RB, Withey JL. A broader concept of Caplan’s syndrome related to rheumatoid factors. Thorax 1962;17:205–212.PubMedCrossRefGoogle Scholar
  117. 117.
    Benedek TG. Rheumatoid pneumoconiosis. Documentation of onset and pathogenic considerations. Am J Med 1973;55:515–524.PubMedCrossRefGoogle Scholar
  118. 118.
    Crystal RG, Rennard SI. Pulmonary connective tissue and environmental lung disease. Chest 1981;80:33–38.PubMedCrossRefGoogle Scholar
  119. 119.
    Ondrasik M. Caplan’s syndrome. Baillieres Clin Rheumatol 1989;3:205–210.PubMedCrossRefGoogle Scholar
  120. 120.
    Arakawa H, Honma K, Shida H, et al. Computed tomography findings of Caplan syndrome. J Comput Assist Tomogr 2003;27:758–760.PubMedCrossRefGoogle Scholar
  121. 121.
    Greaves IA. Rheumatoid “pneumoconiosis” (Caplan’s syndrome) in an asbestos worker: a 17 years’ follow-up. Thorax 1979;34:404–405.PubMedCrossRefGoogle Scholar
  122. 122.
    Tellesson WG. Rheumatoid pneumoconiosis (Caplan’s syndrome) in an asbestos worker. Thorax 1961;16:372–377.PubMedCrossRefGoogle Scholar
  123. 123.
    Sluis-Cremer GK. Respiratory manifestations of rheumatoid arthritis. S Afr Med J 1970;44:843–846.PubMedGoogle Scholar
  124. 124.
    Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981;60:288–297.PubMedCrossRefGoogle Scholar
  125. 125.
    Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986;65:365–375.PubMedCrossRefGoogle Scholar
  126. 126.
    DeHoratius RJ, Abruzzo JL, Williams RC Jr. Immunofluorescent and immunologic studies of rheumatoid lung. Arch Intern Med 1972;129:441–446.PubMedCrossRefGoogle Scholar
  127. 127.
    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-1982. An elderly woman with mild rheumatoid arthritis and progressive pulmonary fibrosis. N Engl J Med 1982;306:157–165.CrossRefGoogle Scholar
  128. 128.
    Lakhanpal S, Conn DL, Lie JT. Clinical and prognostic significance of vasculitis as an early manifestation of connective tissue disease syndromes. Ann Intern Med 1984;101:743–748.PubMedCrossRefGoogle Scholar
  129. 129.
    Kay JM, Banik S. Unexplained pulmonary hypertension with pulmonary arteritis in rheumatoid disease. Br J Dis Chest 1977;71:53–59.PubMedCrossRefGoogle Scholar
  130. 130.
    Baydur A, Mongan ES, Slager UT. Acute respiratory failure and pulmonary arteritis without parenchymal involvement: demonstration in a patient with rheumatoid arthritis. Chest 1979;75:518–520.PubMedCrossRefGoogle Scholar
  131. 131.
    Theofilopoulos AN, Burtonboy G, LoSpalluto JJ, et al. IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum 1974;17:272–284.PubMedCrossRefGoogle Scholar
  132. 132.
    Veys EM, Gabriel PA, Coigne E, et al. Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis. Scand J Rheumatol 1976;5:1–6.PubMedCrossRefGoogle Scholar
  133. 133.
    Braun MG, Csernok E, Schmitt WH, et al. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 1996;23:826–830.PubMedGoogle Scholar
  134. 134.
    Keser G, Capar I, Aksu K, et al. Pulmonary hypertension in rheumatoid arthritis. Scand J Rheumatol 2004;33:244–245.PubMedCrossRefGoogle Scholar
  135. 135.
    Morikawa J, Kitamura K, Habuchi Y, et al. Pulmonary hypertension in a patient with rheumatoid arthritis. Chest 1988;93:876–878.PubMedCrossRefGoogle Scholar
  136. 136.
    Young ID, Ford SE, Ford PM. The association of pulmonary hypertension with rheumatoid arthritis. J Rheumatol 1989;16:1266–1269.PubMedGoogle Scholar
  137. 137.
    Balagopal VP, da Costa P, Greenstone MA. Fatal pulmonary hypertension and rheumatoid vasculitis. Eur Respir J 1995;8:331–333.PubMedCrossRefGoogle Scholar
  138. 138.
    Gardner DL, Duthie JJ, Macleod J, et al. Pulmonary hypertension in rheumatoid arthritis: report of a case with intimal sclerosis of the pulmonary and digital arteries. Scott Med J 1957;2:183–188.PubMedGoogle Scholar
  139. 139.
    Onodera S, Hill JR. Pulmonary Hypertension. Report of a Case in Association with Rheumatoid Arthritis. Ohio State Med J 1965;61:141–144.PubMedGoogle Scholar
  140. 140.
    Armstrong JG, Steele RH. Localised pulmonary arteritis in rheumatoid disease. Thorax 1982;37:313–314.PubMedCrossRefGoogle Scholar
  141. 141.
    Popper MS, Bogdonoff ML, Hughes RL. Interstitial rheumatoid lung disease. A reassessment and review of the literature. Chest 1972;62:243–250.PubMedCrossRefGoogle Scholar
  142. 142.
    Frank ST, Maloney TR, Weg JG. Pulmonary alveolar proteinosis: report of two cases and comments on its pathogenesis. South Med J 1969;62:867–870.PubMedCrossRefGoogle Scholar
  143. 143.
    Laitinen O, Nissila M, Salorinne Y, et al. Pulmonary involvement in patients with rheumatoid arthritis. Scand J Respir Dis 1975;56:297–304.PubMedGoogle Scholar
  144. 144.
    Hill CL, Nguyen AM, Roder D, et al. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728–731.PubMedCrossRefGoogle Scholar
  145. 145.
    Morrison SC, Mody GM, Benatar SR, et al. The lungs in rheumatoid arthritis—a clinical, radiographic and pulmonary function study. S Afr Med J 1996;86:829–833.PubMedGoogle Scholar
  146. 146.
    Chou CW, Chang SC. Pleuritis as a presenting manifestation of rheumatoid arthritis: diagnostic clues in pleural fluid cytology. Am J Med Sci 2002;323:158–161.PubMedCrossRefGoogle Scholar
  147. 147.
    Faurschou P, Francis D, Faarup P. Thoracoscopic, histological, and clinical findings in nine case of rheumatoid pleural effusion. Thorax 1985;40:371–375.PubMedCrossRefGoogle Scholar
  148. 148.
    Champion GD, Robertson MR, Robinson RG. Rheumatoid pleurisy and pericarditis. Ann Rheum Dis 1968;27:521–530.PubMedCrossRefGoogle Scholar
  149. 149.
    Aru A, Engel U, Francis D. Characteristic and specific histological findings in rheumatoid pleurisy. Acta Pathol Microbiol Immunol Scand [A] 1986;94:57–62.Google Scholar
  150. 150.
    Naylor B. The pathognomonic cytologic picture of rheumatoid pleuritis. The 1989 Maurice Goldblatt Cytology award lecture. Acta Cytol 1990;34:465–473.PubMedGoogle Scholar
  151. 151.
    Pettersson T, Klockars M, Hellstrom PE. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax 1982;37:354–361.PubMedCrossRefGoogle Scholar
  152. 152.
    Faurschou P. Decreased glucose in RA-cell-positive pleural effusion: correlation of pleural glucose, lactic dehydrogenase and protein concentration to the presence of RA-cells. Eur J Respir Dis 1984;65:272–277.PubMedGoogle Scholar
  153. 153.
    Walker WC, Wright V. Rheumatoid pleuritis. Ann Rheum Dis 1967;26:467–474.PubMedCrossRefGoogle Scholar
  154. 154.
    Cervantes-Perez P, Toro-Perez AH, Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA 1980;243:1715–1719.PubMedCrossRefGoogle Scholar
  155. 155.
    Sahn SA, Kaplan RL, Maulitz RM, et al. Rheumatoid pleurisy. Observations on the development of low pleural fluid pH and glucose level. Arch Intern Med 1980;140:1237–1238.PubMedCrossRefGoogle Scholar
  156. 156.
    Martel W, Abell MR, Mikkelsen WM, et al. Pulmonary and pleural lesions in rheumatoid disease. Radiology 1968;90:641–653.PubMedGoogle Scholar
  157. 157.
    Wagener JS, Taussig LM, DeBenedetti C, et al. Pulmonary function in juvenile rheumatoid arthritis. J Pediatr 1981;99:108–110.PubMedCrossRefGoogle Scholar
  158. 158.
    Romicka A, Maldyk E. Pulmonary lesions in the course of rheumatoid arthritis in children. Pol Med Sci Hist Bull 1975;15:263–268.PubMedGoogle Scholar
  159. 159.
    Jordan JD, Snyder CH. Rheumatoid disease of the lung and cor pulmonale. Observations in a child. Am J Dis Child 1964;108:174–180.PubMedGoogle Scholar
  160. 160.
    Padeh S, Laxer RM, Silver MM, et al. Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis. Arthritis Rheum 1991;34:1575–1579.PubMedCrossRefGoogle Scholar
  161. 161.
    Uziel Y, Hen B, Cordoba M, et al. Lymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis. Clin Exp Rheumatol 1998;16:617–619.PubMedGoogle Scholar
  162. 162.
    Noyes BE, Albers GM, deMello DE, et al. Early onset of pulmonary parenchymal disease associated with juvenile rheumatoid arthritis. Pediatr Pulmonol 1997;24:444–446.PubMedCrossRefGoogle Scholar
  163. 163.
    Pegg SJ, Lang BA, Mikhail EL, et al. Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving chrysotherapy. J Rheumatol 1994;21:549–551.PubMedGoogle Scholar
  164. 164.
    Lovell D, Lindsley C, Langston C. Lymphoid interstitial pneumonia in juvenile rheumatoid arthritis. J Pediatr 1984;105:947–950.PubMedCrossRefGoogle Scholar
  165. 165.
    Harmon KR, Leatherman JW. Respiratory manifestations of connective tissue disease. Semin Respir Infect 1988;3:258–273.PubMedGoogle Scholar
  166. 166.
    Pertschuk LP, Moccia LF, Rosen Y, et al. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1977;68:553–557.PubMedGoogle Scholar
  167. 167.
    Miller LR, Greenberg SD, McLarty JW. Lupus lung. Chest 1985;88:265–269.PubMedCrossRefGoogle Scholar
  168. 168.
    Murin S, Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998;19:641–665, viii.PubMedCrossRefGoogle Scholar
  169. 169.
    Gross M, Esterly JR, Earle RH. Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1972;105:575–577.Google Scholar
  170. 170.
    Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964;190:104–111.PubMedCrossRefGoogle Scholar
  171. 171.
    Eisenberg H, Dubois EL, Sherwin RP, et al. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973;79:37–45.PubMedCrossRefGoogle Scholar
  172. 172.
    Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981;71:791–798.PubMedCrossRefGoogle Scholar
  173. 173.
    Quismorio FP Jr, Sharma O, Koss M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13:349–359.PubMedCrossRefGoogle Scholar
  174. 174.
    Pines A, Kaplinsky N, Olchovsky D, et al. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985;88:129–135.PubMedCrossRefGoogle Scholar
  175. 175.
    Segal AM, Calabrese LH, Ahmad M, et al. The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 1985;14:202–224.PubMedCrossRefGoogle Scholar
  176. 176.
    Weinrib L, Sharma OP, Quismorio FP Jr. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:48–56.PubMedCrossRefGoogle Scholar
  177. 177.
    Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954;33:291–437.PubMedCrossRefGoogle Scholar
  178. 178.
    Kinney WW, Angelillo VA. Bronchiolitis in systemic lupus erythematosus. Chest 1982;82:646–649.PubMedCrossRefGoogle Scholar
  179. 179.
    Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192–202.PubMedCrossRefGoogle Scholar
  180. 180.
    Eagen JW, Memoli VA, Roberts JL, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978;57:545–560.PubMedCrossRefGoogle Scholar
  181. 181.
    du Bois RM, Wells AU. The lungs and connective tissue diseases. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. Philadelphia: WB Saunders, 2000:1691–1715.Google Scholar
  182. 182.
    Mintz G, Galindo LF, Fernandez-Diez J, et al. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1978;5:39–50.PubMedGoogle Scholar
  183. 183.
    Myers JL, Katzenstein AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552–556.PubMedGoogle Scholar
  184. 184.
    Churg A, Franklin W, Chan KL, et al. Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus. Arch Pathol Lab Med 1980;104:388–391.PubMedGoogle Scholar
  185. 185.
    Lyon MG, Bewtra C, Kenik JG, et al. Tubuloreticular inclusions in systemic lupus pneumonitis. Report of a case and review of the literature. Arch Pathol Lab Med 1984;108:599–600.PubMedGoogle Scholar
  186. 186.
    Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975;54:397–409.PubMedCrossRefGoogle Scholar
  187. 187.
    Carette S, Macher AM, Nussbaum A, et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984;14:52–59.PubMedCrossRefGoogle Scholar
  188. 188.
    Simonson JS, Schiller NB, Petri M, et al. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989;16:918–925.PubMedGoogle Scholar
  189. 189.
    Fayemi AO. Pulmonary vascular disease in systemic lupus erythematosus. Am J Clin Pathol 1976;65:284–290.PubMedGoogle Scholar
  190. 190.
    Nair SS, Askari AD, Popelka CG, et al. Pulmonary hypertension and systemic lupus erythematosus. Arch Intern Med 1980;140:109–111.PubMedCrossRefGoogle Scholar
  191. 191.
    Kanemot ON, Sato M, Moriuchi J, et al. An autopsied case of systemic lupus erythematosus with pulmonary hypertension—a case report. Angiology 1988;39:187–192.CrossRefGoogle Scholar
  192. 192.
    Roncoroni AJ, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration 1992;59:52–56.PubMedCrossRefGoogle Scholar
  193. 193.
    Wakaki K, Koizumi F, Fukase M. Vascular lesions in systemic lupus erythematosus (SLE) with pulmonary hypertension. Acta Pathol Jpn 1984;34:593–604.PubMedGoogle Scholar
  194. 194.
    Yokoi T, Tomita Y, Fukaya M, et al. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med 1998;122:467–470.PubMedGoogle Scholar
  195. 195.
    Rubin LA, Geran A, Rose TH, et al. A fatal pulmonary complication of lupus in pregnancy. Arthritis Rheum 1995;38:710–714.PubMedCrossRefGoogle Scholar
  196. 196.
    Yoshio T, Masuyama J, Mimori A, et al. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 1995;54:361–365.PubMedCrossRefGoogle Scholar
  197. 197.
    Yoshio T, Masuyama J, Sumiya M, et al. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21:2058–2063.PubMedGoogle Scholar
  198. 198.
    Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752–763.PubMedCrossRefGoogle Scholar
  199. 199.
    Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. 500 consecutive patients. Medicine (Baltimore) 1989;68:353–365.PubMedGoogle Scholar
  200. 200.
    Asherson RA, Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol 1995;22:62–66.PubMedGoogle Scholar
  201. 201.
    Eisenberg H. The interstitial lung diseases associated with the collagen-vascular disorders. Clin Chest Med 1982;3:565–578.PubMedGoogle Scholar
  202. 202.
    Hoffbrand BI, Beck ER. “Unexplained” dyspnoea and shrinking lungs in systemic lupus erythematosus. Br Med J 1965;5445:1273–1277.CrossRefGoogle Scholar
  203. 203.
    Chick TW, DeHoratius RJ, Skipper BE, et al. Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms. J Rheumatol 1976;3:262–268.PubMedGoogle Scholar
  204. 204.
    Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE—a clinical pathologic study. J Rheumatol 1983;10:973–976.PubMedGoogle Scholar
  205. 205.
    Martens J, Demedts M, Vanmeenen MT, et al. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983;84:170–175.PubMedCrossRefGoogle Scholar
  206. 206.
    Jacobelli S, Moreno R, Massardo L, et al. Inspiratory muscle dysfunction and unexplained dyspnea in systemic lupus erythematosus. Arthritis Rheum 1985;28:781–788.PubMedCrossRefGoogle Scholar
  207. 207.
    Eichacker PQ, Pinsker K, Epstein A, et al. Serial pulmonary function testing in patients with systemic lupus erythematosus. Chest 1988;94:129–132.PubMedCrossRefGoogle Scholar
  208. 208.
    Karim MY, Miranda LC, Tench CM, et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002;31:289–298.PubMedCrossRefGoogle Scholar
  209. 209.
    Hardy K, Herry I, Attali V, et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001;119:1274–1277.PubMedCrossRefGoogle Scholar
  210. 210.
    Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989;71:429–439.PubMedGoogle Scholar
  211. 211.
    Milligan DW, Chang JG. Systemic lupus erythematosus and lymphoma. Acta Haematol 1980;64:109–110.PubMedCrossRefGoogle Scholar
  212. 212.
    Mellemkjaer L, Andersen V, Linet MS, et al. Non-Hodgkin’s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:761–768.PubMedCrossRefGoogle Scholar
  213. 213.
    Bjornadal L, Lofstrom B, Yin L, et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:66–71.PubMedCrossRefGoogle Scholar
  214. 214.
    Greenfield DI, Trinh P, Fulenwider A, et al. Kaposi’s sarcoma in a patient with SLE. J Rheumatol 1986;13:637–640.PubMedGoogle Scholar
  215. 215.
    Ragnarsson O, Grondal G, Steinsson K. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus 2003;12:687–691.PubMedCrossRefGoogle Scholar
  216. 216.
    Gammon RB, Bridges TA, al-Nezir H, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992;102:1171–1174.PubMedCrossRefGoogle Scholar
  217. 217.
    Mana F, Mets T, Vincken W, et al. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner’s cystitis. Chest 1993;104:642–644.PubMedCrossRefGoogle Scholar
  218. 218.
    Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med 1979;46:398–341.PubMedGoogle Scholar
  219. 219.
    Steen VD, Owens GR, Fino GJ, et al. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985;28:759–767.PubMedCrossRefGoogle Scholar
  220. 220.
    Altman RD, Medsger TA Jr, Bloch DA, et al. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403–413.PubMedCrossRefGoogle Scholar
  221. 221.
    Hesseistrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682–686.CrossRefGoogle Scholar
  222. 222.
    Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232:560–567.PubMedCrossRefGoogle Scholar
  223. 223.
    D’Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428–440.PubMedCrossRefGoogle Scholar
  224. 224.
    Salerni R, Rodnan GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977;86:394–399.PubMedCrossRefGoogle Scholar
  225. 225.
    Ungerer RG, Tashkin DP, Furst D, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983;75:65–74.PubMedCrossRefGoogle Scholar
  226. 226.
    Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986;29:515–524.PubMedCrossRefGoogle Scholar
  227. 227.
    Trell E, Lindstrom C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 1971;30:390–400.PubMedCrossRefGoogle Scholar
  228. 228.
    Steckel RJ, Bein ME, Kelly PM. Pulmonary arterial hypertension in progressive systemic sclerosis. Am J Roentgenol Radium Ther Nucl Med 1975;124:461–464.PubMedCrossRefGoogle Scholar
  229. 229.
    Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088–1093.PubMedCrossRefGoogle Scholar
  230. 230.
    Schachna L, Wigley FM, Chang B, et al. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 2003;124:2098–2104.PubMedCrossRefGoogle Scholar
  231. 231.
    Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516–522.PubMedCrossRefGoogle Scholar
  232. 232.
    Naeye RL. Pulmonary vascular lesions in systemic scleroderma. Dis Chest 1963;44:374–379.PubMedCrossRefGoogle Scholar
  233. 233.
    Weaver AL, Divertie MB, Titus JL. Pulmonary scleroderma. Dis Chest 1968;54:490–498.PubMedCrossRefGoogle Scholar
  234. 234.
    Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978;64:998–1004.PubMedCrossRefGoogle Scholar
  235. 235.
    Cool CD, Kennedy D, Voelkel NF, et al. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997;28:434–442.PubMedCrossRefGoogle Scholar
  236. 236.
    Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990;21:467–474.PubMedCrossRefGoogle Scholar
  237. 237.
    Morassut PA, Walley VM, Smith CD. Pulmonary venoocclusive disease and the CREST variant of scleroderma. Can J Cardiol 1992;8:1055–1058.PubMedGoogle Scholar
  238. 238.
    Kahaleh MB, Leroy EC. Endothelial injury in scleroderma. A protease mechanism. J Lab Clin Med 1983;101:553–560.PubMedGoogle Scholar
  239. 239.
    Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979;149:1326–1335.PubMedCrossRefGoogle Scholar
  240. 240.
    Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296–1304.PubMedCrossRefGoogle Scholar
  241. 241.
    Hachulla E, Coghlan JG. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. Ann Rheum Dis 2004;63:1009–1014.PubMedCrossRefGoogle Scholar
  242. 242.
    Kallenbach J, Prinsloo I, Zwi S. Progressive systemic sclerosis complicated by diffuse pulmonary haemorrhage. Thorax 1977;32:767–770.PubMedCrossRefGoogle Scholar
  243. 243.
    Kim JH, Follett JV, Rice JR, et al. Endobronchial telangiectasias and hemoptysis in scleroderma. Am J Med 1988;84:173–174.PubMedCrossRefGoogle Scholar
  244. 244.
    Bridges AJ, Hsu KC, Dias-Arias AA, et al. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol 1992;19:1136–1140.PubMedGoogle Scholar
  245. 245.
    Shimizu Y, Tsukagoshi H, Nemoto T, et al. Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. Rheumatol Int 2002;22:216–218.PubMedCrossRefGoogle Scholar
  246. 246.
    Benharroch D, Sukenik S, Sacks M. Bronchioloalveolar carcinoma and generalized amyloidosis complicating progressive systemic sclerosis. Hum Pathol 1992;23:839–841.PubMedCrossRefGoogle Scholar
  247. 247.
    Edwards WG Jr, Dines DE. Recurrent spontaneous pneumothorax in diffuse scleroderma. Report of a case. Dis Chest 1966;49:96–98.PubMedCrossRefGoogle Scholar
  248. 248.
    Russell DC, Maloney A, Muir AL. Progressive generalized scleroderma: respiratory failure from primary chest wall involvement. Thorax 1981;36:219–220.PubMedCrossRefGoogle Scholar
  249. 249.
    Chausow AM, Kane T, Levinson D, et al. Reversible hypercapnic respiratory insufficiency in scleroderma caused by respiratory muscle weakness. Am Rev Respir Dis 1984;130:142–144.PubMedGoogle Scholar
  250. 250.
    Talbott JH, Barrocas M. Carcinoma of the lung in progressive systemic sclerosis: a tabular review of the literature and a detailed report of the roentgenographic changes in two cases. Semin Arthritis Rheum 1980;9:191–217.PubMedCrossRefGoogle Scholar
  251. 251.
    Peters-Golden M, Wise RA, Hochberg M, et al. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136–1139.PubMedGoogle Scholar
  252. 252.
    Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336–1340.PubMedCrossRefGoogle Scholar
  253. 253.
    Paksoy N, Elpek O, Ozbilim G, et al. Bronchioloalveolar carcinoma in progressive systemic sclerosis. Report of a case diagnosed by fine needle aspiration cytology. Acta Cytol 1995;39:1182–1186.PubMedGoogle Scholar
  254. 254.
    Rosenthal AK, McLaughlin JK, Gridley G, et al. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910–914.PubMedCrossRefGoogle Scholar
  255. 255.
    Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–407.PubMedCrossRefGoogle Scholar
  256. 256.
    Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med 1970;48:715–723.PubMedCrossRefGoogle Scholar
  257. 257.
    Oddis CV, Conte CG, Steen VD, et al. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol 1990;17:1329–1334.PubMedGoogle Scholar
  258. 258.
    Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614–622.PubMedCrossRefGoogle Scholar
  259. 259.
    Schnabel A, Reuter M, Biederer J, et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003;32:273–284.PubMedCrossRefGoogle Scholar
  260. 260.
    Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297–301.PubMedCrossRefGoogle Scholar
  261. 261.
    Schwarz MI, Matthay RA, Sahn SA, et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976;55:89–104.PubMedCrossRefGoogle Scholar
  262. 262.
    Olsen GN, Swenson EW. Polymyositis and interstitial lung disease. Am Rev Respir Dis 1972;105:611–617.PubMedGoogle Scholar
  263. 263.
    Duncan PE, Griffin JP, Garcia A, et al. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am J Med 1974;57:621–626.PubMedCrossRefGoogle Scholar
  264. 264.
    Lakhanpal S, Lie JT, Conn DL, et al. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23–29.PubMedCrossRefGoogle Scholar
  265. 265.
    Mills ES, Mathews WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956;160:1467–1470.CrossRefGoogle Scholar
  266. 266.
    Lee CS, Chen TL, Tzen CY, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 2002;21:391–396.PubMedCrossRefGoogle Scholar
  267. 267.
    Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest 1981;79:105–107.PubMedCrossRefGoogle Scholar
  268. 268.
    Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extract-able nuclear antigen (ENA). Am J Med 1972;52:148–159.PubMedCrossRefGoogle Scholar
  269. 269.
    Alarcon-Segovia D. Symptomatic Sjogren’s syndrome in mixed connective tissue disease. J Rheumatol 1976;3:191–195.PubMedGoogle Scholar
  270. 270.
    Maddison PJ. Overlap syndromes and mixed connective tissue disease. Curr Opin Rheumatol 1991;3:995–1000.PubMedCrossRefGoogle Scholar
  271. 271.
    Magro CM, Morrison C, Pope-Harman A, et al. Direct and indirect immunofluorescence as a diagnostic adjunct in the interpretation of nonneoplastic medical lung disease. Am J Clin Pathol 2003;119:279–289.PubMedCrossRefGoogle Scholar
  272. 272.
    Watanabe H, Kaise S, Takeda I, et al. Anti-endothelial cell antibodies in the sera of patients with mixed connective tissue disease—the clinical significance. Fukushima J Med Sci 1997;43:13–28.PubMedGoogle Scholar
  273. 273.
    Hosoda Y, Suzuki Y, Takano M, et al. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14:826–830.PubMedGoogle Scholar
  274. 274.
    Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63:92–107.PubMedCrossRefGoogle Scholar
  275. 275.
    O’Connell DJ, Bennett RM. Mixed connective tissue disease—clinical and radiological aspects of 20 cases. Br J Radiol 1977;50:620–625.PubMedCrossRefGoogle Scholar
  276. 276.
    Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124:499–503.PubMedGoogle Scholar
  277. 277.
    Derderian SS, Tellis CJ, Abbrecht PH, et al. Pulmonary involvement in mixed connective tissue disease. Chest 1985;88:45–48.PubMedCrossRefGoogle Scholar
  278. 278.
    Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985;60:813–821.PubMedCrossRefGoogle Scholar
  279. 279.
    Sanchez-Guerrero J, Cesarman G, Alarcon-Segovia D. Massive pulmonary hemorrhage in mixed connective tissue diseases. J Rheumatol 1989;16:1132–1134.PubMedGoogle Scholar
  280. 280.
    Bennett RM, O’Connell DJ. Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980;10:25–51.PubMedCrossRefGoogle Scholar
  281. 281.
    Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998;19:733–746.PubMedCrossRefGoogle Scholar
  282. 282.
    Prakash UB. Lungs in mixed connective tissue disease. J Thorac Imaging 1992;7:55–61.PubMedCrossRefGoogle Scholar
  283. 283.
    Kumanovics G, Zibotics H, Juhasz E, et al. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease. Clin Exp Rheumatol 2001;19:551–559.PubMedGoogle Scholar
  284. 284.
    Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002;22(spec. No.): S 151–165.CrossRefGoogle Scholar
  285. 285.
    Jones MB, Osterholm RK, Wilson RB, et al. Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature. Am J Med 1978;65:855–863.PubMedCrossRefGoogle Scholar
  286. 286.
    Ueda N, Mimura K, Maeda H, et al. Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature. Virchows Arch A Pathol Anat Histopathol 1984;404:335–340.PubMedCrossRefGoogle Scholar
  287. 287.
    Jolliet P, Thorens JB, Chevrolet JC. Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease. Thorax 1995;50:96–97.PubMedCrossRefGoogle Scholar
  288. 288.
    Ozawa T, Ninomiya Y, Honma T, et al. Increased serum angiotensin I-converting enzyme activity in patients with mixed connective tissue disease and pulmonary hypertension. Scand J Rheumatol 1995;24:38–43.PubMedCrossRefGoogle Scholar
  289. 289.
    Rosenberg AM, Petty RE, Cumming GR, et al. Pulmonary hypertension in a child with mixed connective tissue disease. J Rheumatol 1979;6:700–704.PubMedGoogle Scholar
  290. 290.
    Miyasaka N. Pulmonary hypertension complicating mixed connective tissue disease. Intern Med 1998;37:347–348.PubMedCrossRefGoogle Scholar
  291. 291.
    Itoh O, Nishimaki T, Itoh M, et al. Mixed connective tissue disease with severe pulmonary hypertension and extensive subcutaneous calcification. Intern Med 1998;37:421–425.PubMedCrossRefGoogle Scholar
  292. 292.
    Germain MJ, Davidman M. Pulmonary hemorrhage and acute renal failure in a patient with mixed connective tissue disease. Am J Kidney Dis 1984;3:420–424.PubMedGoogle Scholar
  293. 293.
    Horiki T, Fuyuno G, Ishii M, et al. Fatal alveolar hemorrhage in a patient with mixed connective tissue disease presenting polymyositis features. Intern Med 1998;37:554–560.PubMedCrossRefGoogle Scholar
  294. 294.
    Piirainen HI, Helve AT, Tornroth T, et al. Amyloidosis in mixed connective tissue disease. Scand J Rheumatol 1989;18:165–168.PubMedCrossRefGoogle Scholar
  295. 295.
    Hoogsteden HC, van Dongen JJ, van der Kwast TH, et al. Bilateral exudative pleuritis, an unusual pulmonary onset of mixed connective tissue disease. Respiration 1985;48:164–167.PubMedCrossRefGoogle Scholar
  296. 296.
    Martens J, Demedts M. Diaphragm dysfunction in mixed connective tissue disease. A case report. Scand J Rheumatol 1982;11:165–167.PubMedCrossRefGoogle Scholar
  297. 297.
    Martyn JB, Wong MJ, Huang SH. Pulmonary and neuromuscular complications of mixed connective tissue disease: a report and review of the literature. J Rheumatol 1988;15:703–705.PubMedGoogle Scholar
  298. 298.
    Saito Y, Terada M, Takada T, et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002;26:349–357.PubMedCrossRefGoogle Scholar
  299. 299.
    Tanoue LT. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjogren’s syndrome, and relapsing polychondritis. J Thorac Imaging 1992;7:62–77.PubMedCrossRefGoogle Scholar
  300. 300.
    Gratwhol AA, Moutsopoulos HM, Chused TM, et al. Sjogren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977;87:703–706.PubMedCrossRefGoogle Scholar
  301. 301.
    Itescu S. Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 1992;28:247–250.PubMedGoogle Scholar
  302. 302.
    Reveille JD, Wilson RW, Provost TT, et al. Primary Sjogren’s syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 1984;101:748–756.PubMedCrossRefGoogle Scholar
  303. 303.
    Manthorpe R, Frost-Larsen K, Isager H, et al. Sjogren’s syndrome. A review with emphasis on immunological features. Allergy 1981;36:139–153.PubMedCrossRefGoogle Scholar
  304. 304.
    Strimlan CV, Rosenow EC 3rd, Divertie MB, et al. Pulmonary manifestations of Sjogren’s syndrome. Chest 1976;70:354–361.PubMedCrossRefGoogle Scholar
  305. 305.
    Fairfax AJ, Haslam PL, Pavia D, et al. Pulmonary disorders associated with Sjogren’s syndrome. Q J Med 1981;50:279–295.PubMedGoogle Scholar
  306. 306.
    Isenberg DA, Hammond L, Fisher C, et al. Predictive value of SS-B precipitating antibodies in Sjogren’s syndrome. Br Med J (Clin Res Ed) 1982;284:1738–1740.CrossRefGoogle Scholar
  307. 307.
    Quismorio FP Jr. Pulmonary involvement in primary Sjogren’s syndrome. Curr Opin Pulm Med 1996;2:424–428.PubMedCrossRefGoogle Scholar
  308. 308.
    Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med 1998;19:687–699, viii.PubMedCrossRefGoogle Scholar
  309. 309.
    Papathanasiou MP, Constantopoulos SH, Tsampoulas C, et al. Reappraisal of respiratory abnormalities in primary and secondary Sjogren’s syndrome. A controlled study. Chest 1986;90:370–374.PubMedCrossRefGoogle Scholar
  310. 310.
    Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjogren’s syndrome. A clinical, functional, and histologic study. Chest 1985;88:226–229.PubMedCrossRefGoogle Scholar
  311. 311.
    Bloch KJ, Buchanan WW, Wohl MJ, et al. Sjogren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1992;71:386–401; discussion 403.PubMedCrossRefGoogle Scholar
  312. 312.
    Constantopoulos SH, Tsianos EV, Moutsopoulos HM. Pulmonary and gastrointestinal manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 1992;18:617–635.PubMedGoogle Scholar
  313. 313.
    Dalavanga YA, Constantopoulos SH, Galanopoulou V, et al. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren’s syndrome. Chest 1991;99:1394–1397.PubMedCrossRefGoogle Scholar
  314. 314.
    Gardiner P, Ward C, Allison A, et al. Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol 1993;20:831–837.PubMedGoogle Scholar
  315. 315.
    Fox RI, Howell FV, Bone RC, et al. Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 1984;14:77–105.PubMedCrossRefGoogle Scholar
  316. 316.
    Strimlan CV. Interstitial lung disease and primary Sjogren’s syndrome: clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1997;155:1489.PubMedCrossRefGoogle Scholar
  317. 317.
    Deheinzelin D, Capelozzi VL, Kairalla RA, et al. Interstitial lung disease in primary Sjogren’s syndrome. Clinicalpathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794–799.PubMedCrossRefGoogle Scholar
  318. 318.
    Bucher UG, Reid L. Sjogren’s syndrome: report of a fatal case with pulmonary and renal lesions. Br J Dis Chest 1959;53:237–252.PubMedCrossRefGoogle Scholar
  319. 319.
    Constantopoulos SH, Drosos AA, Maddison PJ, et al. Xerotrachea and interstitial lung disease in primary Sjogren’s syndrome. Respiration 1984;46:310–314.PubMedCrossRefGoogle Scholar
  320. 320.
    Bariffi F, Pesci A, Bertorelli G, et al. Pulmonary involvement in Sjogren’s syndrome. Respiration 1984;46:82–87.PubMedCrossRefGoogle Scholar
  321. 321.
    Newball HH, Brahim SA. Chronic obstructive airway disease in patients with Sjogren’s syndrome. Am Rev Respir Dis 1977;115:295–304.PubMedGoogle Scholar
  322. 322.
    Matteson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia and Sjogren’s syndrome. J Rheumatol 1990;17:676–679.PubMedGoogle Scholar
  323. 323.
    Kadota J, Kusano S, Kawakami K, et al. Usual interstitial pneumonia associated with primary Sjogren’s syndrome. Chest 1995;108:1756–1758.PubMedCrossRefGoogle Scholar
  324. 324.
    Usui Y, Kimula Y, Miura H, et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjogren’s syndrome who died of superimposed diffuse alveolar damage. Respiration 1992;59:122–124.PubMedCrossRefGoogle Scholar
  325. 325.
    Franquet T, Gimenez A, Monill JM, et al. Primary Sjogren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997;169:655–658.PubMedCrossRefGoogle Scholar
  326. 326.
    Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome. Clin Exp Immunol 1972;10:199–221.PubMedGoogle Scholar
  327. 327.
    Weisbrot IM. Lymphomatoid granulomatosis of the lung, associated with a long history of benign lymphoepithelial lesions of the salivary glands and lymphoid interstitial pneumonitis. Report of a case. Am J Clin Pathol 1976;66:792–801.PubMedGoogle Scholar
  328. 328.
    Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren’s syndrome. Mayo Clin Proc 1989;64:920–931.PubMedCrossRefGoogle Scholar
  329. 329.
    Asherson RA, Muncey F, Pambakian H, et al. Sjogren’s syndrome and fibrosing alveolitis complicated by pulmonary lymphoma. Ann Rheum Dis 1987;46:701–705.PubMedCrossRefGoogle Scholar
  330. 330.
    Bonner H Jr, Ennis RS, Geelhoed GW, et al. Lymphoid infiltration and amyloidosis of lung in Sjogren’s syndrome. Arch Pathol 1973;95:42–44.PubMedGoogle Scholar
  331. 331.
    Faguet GB, Webb HH, Agee JF, et al. Immunologically diagnosed malignancy in Sjogren’s pseudolymphoma. Am J Med 1978;65:424–429.PubMedCrossRefGoogle Scholar
  332. 332.
    Ferreiro JE, Robalino BD, Saldana MJ. Primary Sjogren’s syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis. Am J Med 1987;82:1227–1232.PubMedCrossRefGoogle Scholar
  333. 333.
    Koss MN, Hochholzer L, Langloss JM, et al. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 1987;19:178–185.PubMedCrossRefGoogle Scholar
  334. 334.
    Taniguchi M, Sato A, Honda K, et al. Bronchopulmonary manifestations of Sjogren’s syndrome: the findings of the BAL, TBLB, and bronchoscopy. Panminerva Med 1986;28:249–251.PubMedGoogle Scholar
  335. 335.
    Tsuzaka K, Akama H, Yamada H, et al. Pulmonary pseudolymphoma presented with a mass lesion in a patient with primary Sjogren’s syndrome: beneficial effect of intermittent intravenous cyclophosphamide. Scand J Rheumatol 1993;22:90–93.PubMedCrossRefGoogle Scholar
  336. 336.
    Schuurman HJ, Gooszen HC, Tan IW, et al. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjogren’s syndrome. Histopathology 1987;11:1193–1204.PubMedCrossRefGoogle Scholar
  337. 337.
    Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973;57:809–843.PubMedGoogle Scholar
  338. 338.
    Ebihara Y, Sagawa H, Kitazawa Y. Lymphomatoid granulomatosis (Liebow). Acta Pathol Jpn 1982;32:641–648.PubMedGoogle Scholar
  339. 339.
    Capron F, Audouin J, Diebold J, et al. Pulmonary polymorphic centroblastic type malignant lymphoma in a patient with lymphomatoid granulomatosis, Sjogren syndrome and other manifestations of a dysimmune state. Pathol Res Pract 1985;179:656–665.PubMedCrossRefGoogle Scholar
  340. 340.
    Mariette X. Lymphomas in patients with Sjogren’s syndrome: review of the literature and Physiopathologic hypothesis. Leuk Lymphoma 1999;33:93–99.PubMedGoogle Scholar
  341. 341.
    Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888–892.PubMedCrossRefGoogle Scholar
  342. 342.
    Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997;90:766–775.PubMedGoogle Scholar
  343. 343.
    Jaffee ES, Harris NL, Stein H, et al., eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.Google Scholar
  344. 344.
    Travis WD, Koss MN, Ferrans VJ. The lung in connective tissue disorders. In: Hasleton PS, ed. Spencer’s pathology of the lung. 5th ed. New York: McGraw-Hill, 1996:822–823.Google Scholar
  345. 345.
    Rodriguez-Roisin R, Pares A, Bruguera M, et al. Pulmonary involvement in primary biliary cirrhosis. Thorax 1981;36:208–212.PubMedCrossRefGoogle Scholar
  346. 346.
    Deheinzelin D, de Carvalho CR, Tomazini ME, et al. Association of Sjogren’s syndrome and sarcoidosis. Report of a case. Sarcoidosis 1988;5:68–70.PubMedGoogle Scholar
  347. 347.
    Lois M, Roman J, Holland W, et al. Coexisting Sjogren’s syndrome and sarcoidosis in the lung. Semin Arthritis Rheum 1998;28:31–40.PubMedCrossRefGoogle Scholar
  348. 348.
    Hernandez JL, Rodrigo E, De Francisco AL, et al. ANCA-associated pauci-immune crescentic glomerulonephritis complicating Sjogren’s syndrome. Nephrol Dial Transplant 1996;11:2313–2315.PubMedCrossRefGoogle Scholar
  349. 349.
    Kamachi M, Migita K, Tominaga M, et al. Sjogren’s syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis. Nephrol Dial Transplant 1999;14:1033–1034.PubMedCrossRefGoogle Scholar
  350. 350.
    Young C, Hunt S, Watkinson A, et al. Sjogren’s syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3. Scand J Rheumatol 2000;29:267–269.PubMedCrossRefGoogle Scholar
  351. 351.
    Inase N, Usui Y, Tachi H, et al. Sjogren’s syndrome with bronchial gland involvement and multiple bullae. Respiration 1990;57:286–288.PubMedCrossRefGoogle Scholar
  352. 352.
    Kobayashi H, Matsuoka R, Kitamura S, et al. Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 1988;94:438–440.PubMedCrossRefGoogle Scholar
  353. 353.
    Ichikawa Y, Kinoshita M, Koga T, et al. Lung cyst formation in lymphocytic interstitial pneumonia: CT features. J Comput Assist Tomogr 1994;18:745–748.PubMedCrossRefGoogle Scholar
  354. 354.
    Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999;212:567–572.PubMedGoogle Scholar
  355. 355.
    Desai SR, Nicholson AG, Stewart S, et al. Benign pulmonary lymphocytic infiltration and amyloidosis: computed tomographic and pathologic features in three cases. J Thorac Imaging 1997;12:215–220.PubMedCrossRefGoogle Scholar
  356. 356.
    Polansky SM, Ravin CE. Nodular pulmonary infiltrate in a patient with Sjogren’s syndrome. Chest 1980;77:411–412.PubMedCrossRefGoogle Scholar
  357. 357.
    Batra P, Collins JD, Magidson JG. Pulmonary nodular amyloidosis presenting as Sjogren’s syndrome. J Natl Med Assoc 1983;75:903–905.PubMedGoogle Scholar
  358. 358.
    Eri Z, Stanic J, Duric D, et al. Nodular amyloidosis of the lungs associated with Sjogren’s syndrome. Plucne Bolesti 1990;42:153–155.PubMedGoogle Scholar
  359. 359.
    Nakamura N, Yamada G, Itoh T, et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjogren’s syndrome. Intern Med 2002;41:309–311.PubMedCrossRefGoogle Scholar
  360. 360.
    Hedgpeth MT, Boulware DW. Pulmonary hypertension in primary Sjogren’s syndrome. Ann Rheum Dis 1988;47:251–253.PubMedCrossRefGoogle Scholar
  361. 361.
    Sato T, Matsubara O, Tanaka Y, et al. Association of Sjogren’s syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol 1993;24:199–205.PubMedCrossRefGoogle Scholar
  362. 362.
    Sowa JM. The association of Sjogren’s syndrome and primary pulmonary hypertension. Hum Pathol 1993;24:1035–1036.PubMedCrossRefGoogle Scholar
  363. 363.
    Ogihara T, Nakatani A, Ito H, et al. Sjogren’s syndrome with pleural effusion. Intern Med 1995;34:811–814.PubMedCrossRefGoogle Scholar
  364. 364.
    Lahdensuo A, Korpela M. Pulmonary findings in patients with primary Sjogren’s syndrome. Chest 1995;108:316–319.PubMedCrossRefGoogle Scholar
  365. 365.
    Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613–2614.PubMedCrossRefGoogle Scholar
  366. 366.
    McGuigan LE, Geczy AF, Edmonds JP. The immunopa-thology of ankylosing spondylitis—a review. Semin Arthritis Rheum 1985;15:81–105.PubMedCrossRefGoogle Scholar
  367. 367.
    van der Linden SM, Valkenburg HA, de Jongh BM, et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241–249.PubMedCrossRefGoogle Scholar
  368. 368.
    van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol 1983;22:18–19.PubMedCrossRefGoogle Scholar
  369. 369.
    Schlosstein L, Terasaki PI, Bluestone R, et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704–706.PubMedCrossRefGoogle Scholar
  370. 370.
    Lee-Chiong TL Jr. Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis. Clin Chest Med 1998;19:747–757, ix.PubMedCrossRefGoogle Scholar
  371. 371.
    Dunham CL, Kautz FG. Spondylarthritis ankylopoietica: a review and report of twenty cases. Am J Med Sci 1941;201:232–250.CrossRefGoogle Scholar
  372. 372.
    Hillerdal G. Ankylosing spondylitis lung disease—an underdiagnosed entity? Eur J Respir Dis 1983;64:437–441.PubMedGoogle Scholar
  373. 373.
    Rosenow E, Strimlan CV, Muhm JR, et al. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977;52:641–649.PubMedGoogle Scholar
  374. 374.
    Campbell AH, Macdonald CB. Upper lobe fibrosis associated with ankylosing spondylitis. Br J Dis Chest 1965;59:90–101.PubMedCrossRefGoogle Scholar
  375. 375.
    Vale JA, Pickering JG, Scott GW. Ankylosing spondylitis and upper lobe fibrosis and cavitation. Guys Hosp Rep 1974;123:97–119.PubMedGoogle Scholar
  376. 376.
    Davies D. Ankylosing spondylitis and lung fibrosis. Q J Med 1972;41:395–417.PubMedGoogle Scholar
  377. 377.
    Hurwitz SS, Conlan AA, Krige LP. Fibrocavitating pulmonary lesions in ankylosing spondylitis. S Afr Med J 1982;61:168–170.PubMedGoogle Scholar
  378. 378.
    Rumancik WM, Firooznia H, Davis MS Jr, et al. Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr 1984;8:225–229.PubMedCrossRefGoogle Scholar
  379. 379.
    Boushea DK, Sundstrom WR. The pleuropulmonary manifestations of ankylosing spondylitis. Semin Arthritis Rheum 1989;18:277–281.PubMedCrossRefGoogle Scholar
  380. 380.
    Feltelius N, Hedenstrom H, Hillerdal G, et al. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis 1986;45:736–740.PubMedCrossRefGoogle Scholar
  381. 381.
    Cohen AA, Natelson EA, Fechner RE. Fibrosing interstitial pneumonitis in ankylosing spondylitis. Chest 1971;59:369–371.PubMedCrossRefGoogle Scholar
  382. 382.
    Crompton GK, Cameron SJ, Langlands AO. Pulmonary fibrosis, pulmonary tuberculosis and ankylosing spondylitis. Br J Dis Chest 1974;68:51–56.PubMedCrossRefGoogle Scholar
  383. 383.
    Appelrouth D, Gottlieb NL. Pulmonary manifestations of ankylosing spondylitis. J Rheumatol 1975;2:446–453.PubMedGoogle Scholar
  384. 384.
    Chakera TM, Howarth FH, Kendall MJ, et al. The chest radiograph in ankylosing spondylitis. Clin Radiol 1975;26:455–459.PubMedCrossRefGoogle Scholar
  385. 385.
    Wolson AH, Rohwedder JJ. Upper lobe fibrosis in ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med 1975;124:466–471.PubMedCrossRefGoogle Scholar
  386. 386.
    Libshitz HI, Atkinson GW. Pulmonary cystic disease in ankylosing spondylitis: two cases with unusual superinfection. J Can Assoc Radiol 1978;29:266–268.PubMedGoogle Scholar
  387. 387.
    Kchir MM, Mtimet S, Kochbati S, et al. Bronchoalveolar lavage and transbronchial biopsy in spondyloarthropathies. J Rheumatol 1992;19:913–916.PubMedGoogle Scholar
  388. 388.
    Levy H, Hurwitz MD, Strimling M, et al. Ankylosing spondylitis lung disease and Mycobacterium scrofulaceum. Br J Dis Chest 1988;82:84–87.PubMedCrossRefGoogle Scholar
  389. 389.
    Blavia R, Toda MR, Vidal F, et al. Pulmonary diffuse amyloidosis and ankylosing spondylitis. A rare association. Chest 1992;102:1608–1610.PubMedCrossRefGoogle Scholar
  390. 390.
    Gupta SM, Johnston WH. Apical pulmonary disease in ankylosing spondylitis. N Z Med J 1978;88:186–188.PubMedGoogle Scholar
  391. 391.
    Hakala M, Kontkanen E, Koivisto O. Simultaneous presentation of upper lobe fibrobullous disease and spinal pseudarthrosis in a patient with ankylosing spondylitis. Ann Rheum Dis 1990;49:728–729.PubMedCrossRefGoogle Scholar
  392. 392.
    Crompton GK, Cameron SJ, Langlands AO, et al. Pulmonary fibrosis, mimicking tuberculosis, presenting before joint symptoms in a female with ankylosing spondylitis. Tubercle 1973;54:317–320.PubMedCrossRefGoogle Scholar
  393. 393.
    Shankar PS. Ankylosing spondylitis with fibrosis and carcinoma of the lung. CA Cancer J Clin 1982;32:177–179.PubMedCrossRefGoogle Scholar
  394. 394.
    Ahern MJ, Maddison P, Mann S, et al. Ankylosing spondylitis and adenocarcinoma of the lung. Ann Rheum Dis 1982;41:292–294.PubMedCrossRefGoogle Scholar
  395. 395.
    Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 1994;59:327–338.PubMedCrossRefGoogle Scholar
  396. 396.
    Molina M, Ortega G, Cuesta F, et al. Pulmonary hemorrhage associated with ankylosing spondylitis. An Med Interna 1994;11:150.PubMedGoogle Scholar
  397. 397.
    Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002;126:1064–1070.PubMedGoogle Scholar
  398. 398.
    Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960;263:51–58.PubMedCrossRefGoogle Scholar
  399. 399.
    Gibson GJ, Davis P. Respiratory complications of relapsing polychondritis. Thorax 1974;29:726–731.PubMedCrossRefGoogle Scholar
  400. 400.
    Herman JH. Polychondritis. Curr Opin Rheumatol 1991;3:28–31.PubMedCrossRefGoogle Scholar
  401. 401.
    McAdam LP, O’Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976;55:193–215.PubMedCrossRefGoogle Scholar
  402. 402.
    Michet CJ Jr, McKenna CH, Luthra HS, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986;104:74–78.PubMedCrossRefGoogle Scholar
  403. 403.
    Eng J, Sabanathan S. Airway complications in relapsing polychondritis. Ann Thorac Surg 1991;51:686–692.PubMedCrossRefGoogle Scholar
  404. 404.
    Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Intern Med 1923;6:93–100.Google Scholar
  405. 405.
    Atherr F. Uber einen Fall von systematiseirter Chondromalacie. Virchows Arch A Pathol Anat Histopathol 1936;297:445–479.CrossRefGoogle Scholar
  406. 406.
    Hughes RA, Berry CL, Seifert M, et al. Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med 1972;41:363–380.PubMedGoogle Scholar
  407. 407.
    von Meyerburg R. Ueber chondromalacie. Schweiz Med Wochenschr 1936;17:1239–1240.Google Scholar
  408. 408.
    Kaye RL, Sones DA. Relapsing polychondritis. Clinical and pathologic features in fourteen cases. Ann Intern Med 1964;60:653–664.PubMedCrossRefGoogle Scholar
  409. 409.
    Verity MA, Larson WM, Madden SC. Relapsing polychondritis. Report of two necropsied cases with histochemical investigation of the cartilage lesion. Am J Pathol 1963;42:251–269.PubMedGoogle Scholar
  410. 410.
    Dolan DL, Lemmon GB Jr, Teitelbaum SL. Relapsing polychondritis. Analytical literature review and studies on pathogenesis. Am J Med 1966;41:285–299.PubMedCrossRefGoogle Scholar
  411. 411.
    Arkin CR, Masi AT. Relapsing polychondritis: review of current status and case report. Semin Arthritis Rheum 1975;5:41–62.PubMedCrossRefGoogle Scholar
  412. 412.
    Giroux L, Paquin F, Guerard-Desjardins MJ, et al. Relapsing polychondritis: an autoimmune disease. Semin Arthritis Rheum 1983;13:182–187.PubMedCrossRefGoogle Scholar
  413. 413.
    Ebringer R, Rook G, Swana GT, et al. Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 1981;40:473–479.PubMedCrossRefGoogle Scholar
  414. 414.
    Valenzuela R, Cooperrider PA, Gogate P, et al. Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens. Hum Pathol 1980;11:19–22.PubMedCrossRefGoogle Scholar
  415. 415.
    Rauh G, Dorfler H, Erlinger R, et al. Relapsing poly(peri)chondritis associated with fibrosing alveolar disease and antibodies to pneumocytes type II and Clara cells. Klin Wochenschr 1989;67:784–789.PubMedCrossRefGoogle Scholar
  416. 416.
    Krell WS, Staats BA, Hyatt RE. Pulmonary function in relapsing polychondritis. Am Rev Respir Dis 1986;133:1120–1123.PubMedGoogle Scholar
  417. 417.
    Higenbottam T, Cochrane GM, Clark TJ, et al. Bronchial disease in ulcerative colitis. Thorax 1980;35:581–585.PubMedCrossRefGoogle Scholar
  418. 418.
    Rogerson ME, Higgins EM, Godfrey RC. Tracheal stenosis due to relapsing polychondritis in rheumatoid arthritis. Thorax 1987;42:905–906.PubMedCrossRefGoogle Scholar
  419. 419.
    Sheffield E, Corrin B. Fatal bronchial stenosis due to isolated relapsing chondritis. Histopathology 1992;20:442–443.PubMedCrossRefGoogle Scholar
  420. 420.
    Kindblom LG, Dalen P, Edmar G, et al. Relapsing polychondritis. A clinical, pathologic-anatomic and histochemical study of 2 cases. Acta Pathol Microbiol Scand [A] 1977;85:656–664.Google Scholar
  421. 421.
    Faul JL, Kee ST, Rizk NW. Endobronchial stenting for severe airway obstruction in relapsing polychondritis. Chest 1999;116:825–827.PubMedCrossRefGoogle Scholar
  422. 422.
    Wu S, Sagawa M, Suzuki S, et al. Pulmonary fibrosis with intractable pneumothorax: new pulmonary manifestation of relapsing polychondritis. Tohoku J Exp Med 2001;194:191–195.PubMedCrossRefGoogle Scholar
  423. 423.
    Svenson KL, Holmdahl R, Klareskog L, et al. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol 1984;13:329–333.PubMedCrossRefGoogle Scholar
  424. 424.
    Neilly JB, Winter JH, Stevenson RD. Progressive tracheobronchial polychondritis: need for early diagnosis. Thorax 1985;40:78–79.PubMedCrossRefGoogle Scholar
  425. 425.
    Crockford MP, Kerr IH. Relapsing polychondritis. Clin Radiol 1988;39:386–390.PubMedCrossRefGoogle Scholar
  426. 426.
    Lipnick RN, Fink CW. Acute airway obstruction in relapsing polychondritis: treatment with pulse methylprednisolone. J Rheumatol 1991;18:98–99.PubMedGoogle Scholar
  427. 427.
    Burlew BP, Lippton H, Klinestiver D, et al. Relapsing polychondritis: new pulmonary manifestations. J La State Med Soc 1992;144:58–62.PubMedGoogle Scholar
  428. 428.
    Fairley C, Wilson JW, Barraclough D. Pulmonary involvement in Behcet’s syndrome. Chest 1989;96:1428–1429.PubMedCrossRefGoogle Scholar
  429. 429.
    Raz I, Okon E, Chajek-Shaul T. Pulmonary manifestations in Behcet’s syndrome. Chest 1989;95:585–589.PubMedCrossRefGoogle Scholar
  430. 430.
    Efthimiou J, Johnston C, Spiro SG, et al. Pulmonary disease in Behcet’s syndrome. Q J Med 1986;58:259–280.PubMedGoogle Scholar
  431. 431.
    Grenier P, Bletry O, Cornud F, et al. Pulmonary involvement in Behcet disease. AJR Am J Roentgenol 1981;137:565–569.PubMedCrossRefGoogle Scholar
  432. 432.
    Chajek T, Fainaru M. Behcet’s disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975;54:179–196.PubMedCrossRefGoogle Scholar
  433. 433.
    Cadman EC, Lundberg WB, Mitchell MS. Pulmonary manifestations in Behcet syndrome. Case report and review of the literature. Arch Intern Med 1976;136:944–947.PubMedCrossRefGoogle Scholar
  434. 434.
    Adorno D, Pezzi PP, Bonini S, et al. HLA-B5 and Behcet’s disease. Tissue Antigens 1979;14:444–448.PubMedCrossRefGoogle Scholar
  435. 435.
    Nishiyama M, Nakae K, Umehara T. A study of familial occurrence of Behcet’s disease with and without ocular lesions. Jpn J Ophthalmol 2001;45:313–316.PubMedCrossRefGoogle Scholar
  436. 436.
    Erkan F, Gul A, Tasali E. Pulmonary manifestations of Behcet’s disease. Thorax 2001;56:572–578.PubMedCrossRefGoogle Scholar
  437. 437.
    Hamuryudan V, Yurdakul S, Moral F, et al. Pulmonary arterial aneurysms in Behcet’s syndrome: a report of 24 cases. Br J Rheumatol 1994;33:48–51.PubMedCrossRefGoogle Scholar
  438. 438.
    Dreisin RB. Pulmonary vasculitis. Clin Chest Med 1982;3:607–618.PubMedGoogle Scholar
  439. 439.
    Corren J. Acute interstitial pneumonia in a patient with Behcet’s syndrome and common variable immunodeficiency. Ann Allergy 1990;64:15–20.PubMedGoogle Scholar
  440. 440.
    Davies JD. Behcet’s syndrome with haemoptysis and pulmonary lesions. J Pathol 1973;109:351–356.PubMedCrossRefGoogle Scholar
  441. 441.
    Slavin RE, de Groot WJ. Pathology of the lung in Behcet’s disease. Case report and review of the literature. Am J Surg Pathol 1981;5:779–788.PubMedCrossRefGoogle Scholar
  442. 442.
    Lie JT. Vascular involvement in Behcet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341–343.PubMedGoogle Scholar
  443. 443.
    Jerray M, Benzarti M, Rouatbi N. Possible Behcet’s disease revealed by pulmonary aneurysms. Chest 1991;99:1282–1284.PubMedCrossRefGoogle Scholar
  444. 444.
    de Montpreville VT, Macchiarini P, Dartevelle PG, et al. Large bilateral pulmonary artery aneurysms in Behcet’s disease: rupture of the contralateral lesion after aneurys-morrhaphy. Respiration 1996;63:49–51.PubMedCrossRefGoogle Scholar
  445. 445.
    Abadoglu O, Osma E, Ucan ES, et al. Behcet’s disease with pulmonary involvement, superior vena cava syndrome, chyloptysis and chylous ascites. Respir Med 1996;90:429–431.PubMedCrossRefGoogle Scholar
  446. 446.
    Gul A, Yilmazbayhan D, Buyukbabani N, et al. Organizing pneumonia associated with pulmonary artery aneurysms in Behcet’s disease. Rheumatology (Oxford) 1999;38:1285–1289.PubMedCrossRefGoogle Scholar
  447. 447.
    Erkan F, Kiyan E, Tunaci A. Pulmonary complications of Behcet’s disease. Clin Chest Med 2002;23:493–503.PubMedCrossRefGoogle Scholar
  448. 448.
    Witt C, John M, Martin H, et al. Behcet’s syndrome with pulmonary involvement-combined therapy for endobronchial stenosis using neodymium-YAG laser, balloon dilation and immunosuppression. Respiration 1996;63:195–198.PubMedCrossRefGoogle Scholar
  449. 449.
    Kopp WL, Green RA. Pulmonary artery aneurysms with recurrent thrombophlebitis. The “Hughes-Stovin syndrome.” Ann Intern Med 1962;56:105–114.PubMedCrossRefGoogle Scholar
  450. 450.
    Doyle JA, Ginsburg WW. Eosinophilic fasciitis. Med Clin North Am 1989;73:1157–1166.PubMedGoogle Scholar
  451. 451.
    Rodnan GP, DiBartolomeo A, Medsger TA Jr. Proceedings: eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum 1975;18:525.PubMedCrossRefGoogle Scholar
  452. 452.
    Doyle JA. Eosinophilic fasciitis: extracutaneous manifestations and associations. Cutis 1984;34:259–261.PubMedGoogle Scholar
  453. 453.
    Killen JW, Swift GL, White RJ. Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J 2000;76:36–37.PubMedCrossRefGoogle Scholar
  454. 454.
    Silver RM, Heyes MP, Maize JC, et al. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990;322:874–881.PubMedCrossRefGoogle Scholar
  455. 455.
    Maddison PJ. Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis. Ann Rheum Dis 1991;50Suppl 4:887–893.PubMedCrossRefGoogle Scholar
  456. 456.
    Milewicz DM, Urban Z, Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol 2000;19:471–480.PubMedCrossRefGoogle Scholar
  457. 457.
    Kim JM, Su WP. Mid dermal elastolysis with wrinkling. Report of two cases and review of the literature. J Am Acad Dermatol 1992;26:169–173.PubMedCrossRefGoogle Scholar
  458. 458.
    Mehregan AH, Lee SC, Nabai H. Cutis laxa (generalized elastolysis). A report of four cases with autopsy findings. J Cutan Pathol 1978;5:116–126.PubMedCrossRefGoogle Scholar
  459. 459.
    Corbett E, Glaisyer H, Chan C, et al. Congenital cutis laxa with a dominant inheritance and early onset emphysema. Thorax 1994;49:836–837.PubMedCrossRefGoogle Scholar
  460. 460.
    Sayers CP, Goltz RW, Mottiaz J. Pulmonary elastic tissue in generalized elastolysis (cutis laxa) and Marfan’s syndrome: a light and electron microscopic study. J Invest Dermatol 1975;65:451–457.PubMedCrossRefGoogle Scholar
  461. 461.
    Turner-Stokes L, Turton C, Pope FM, et al. Emphysema and cutis laxa. Thorax 1983;38:790–792.PubMedCrossRefGoogle Scholar
  462. 462.
    Ayres JG, Pope FM, Reidy JF, et al. Abnormalities of the lungs and thoracic cage in the Ehlers-Danlos syndrome. Thorax 1985;40:300–305.PubMedCrossRefGoogle Scholar
  463. 463.
    Murray RA, Poulton TB, Saltarelli MG, et al. Rare pulmonary manifestation of Ehlers-Danlos syndrome. Journal of Thoracic Imaging 1995;10:138–141.PubMedCrossRefGoogle Scholar
  464. 464.
    Corrin B, Simpson CG, Fisher C. Fibrous pseudotumours and cyst formation in the lungs in Ehlers-Danlos syndrome. Histopathology 1990;17:478–479.PubMedCrossRefGoogle Scholar
  465. 465.
    Yost BA, Vogelsang JP, Lie JT. Fatal hemoptysis in Ehlers-Danlos syndrome. Old malady with a new curse. Chest 1995;107:1465–1467.PubMedCrossRefGoogle Scholar
  466. 466.
    Aaby GV, Blake HA. Tracheobronchiomegaly. Ann Thorac Surg 1966;2:64–70.PubMedCrossRefGoogle Scholar
  467. 467.
    Wanderer AA, Ellis EF, Goltz RW, et al. Tracheobronchiomegaly and acquired cutis laxa in a child. Physiologic and immunologic studies. Pediatrics 1969;44:709–715.PubMedGoogle Scholar
  468. 468.
    Hu X, Plomp AS, van Soest S, et al. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol 2003;48:424–438.PubMedCrossRefGoogle Scholar
  469. 469.
    Sherer DW, Sapadin AN, Lebwohl MG. Pseudoxanthoma elasticum: an update. Dermatology 1999;199:3–7.PubMedCrossRefGoogle Scholar
  470. 470.
    Jackson A, Loh CL. Pulmonary calcification and elastic tissue damage in pseudoxanthoma elasticum. Histopathology 1980;4:607–611.PubMedCrossRefGoogle Scholar
  471. 471.
    Eng AM, Bryant J. Clinical pathologic observations in pseudoxanthoma elasticum. Int J Dermatol 1975;14:586–605.PubMedCrossRefGoogle Scholar
  472. 472.
    Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med 1979;300:772–777.PubMedCrossRefGoogle Scholar
  473. 473.
    Bamforth S, Hayden MR. Pulmonary emphysema in a neonate with the Marfan syndrome. Pediatr Radiol 1988;18:88.PubMedCrossRefGoogle Scholar
  474. 474.
    Day DL, Burke BA. Pulmonary emphysema in a neonate with Marfan syndrome. Pediatr Radiol 1986;16:518–521.PubMedCrossRefGoogle Scholar
  475. 475.
    Day DL. Pulmonary emphysema in a neonate with Marfan syndrome. Pediatr Radiol 1988;18:179.PubMedCrossRefGoogle Scholar
  476. 476.
    Reye RD, Bale PM. Elastic tissue in pulmonary emphysema in Marfan syndrome. Arch Pathol 1973;96:427–431.PubMedGoogle Scholar
  477. 477.
    Tewari SC, Jayaswal R, Jetley RK, et al. Pulmonary bullous disease in Marfan syndrome. J Assoc Physicians India 1990;38:587–589.PubMedGoogle Scholar
  478. 478.
    Turner JA, Stanley NN. Fragile lung in the Marfan syndrome. Thorax 1976;31:771–775.PubMedCrossRefGoogle Scholar
  479. 479.
    Yellin A, Shiner RJ, Lieberman Y. Familial multiple bilateral pneumothorax associated with Marfan syndrome. Chest 1991;100:577–578.PubMedCrossRefGoogle Scholar
  480. 480.
    Hall JR, Pyeritz RE, Dudgeon DL, et al. Pneumothorax in the Marfan syndrome: prevalence and therapy. Ann Thorac Surg 1984;37:500–504.PubMedCrossRefGoogle Scholar
  481. 481.
    Sensenig DM, LaMarche P. Marfan’s syndrome and spontaneous pneumothorax. Am J Surg 1980;139:602–604.PubMedCrossRefGoogle Scholar
  482. 482.
    Gawkrodger DJ. Marfan’s syndrome presenting as bilateral spontaneous pneumothorax. Postgrad Med J 1981;57:240–241.PubMedCrossRefGoogle Scholar
  483. 483.
    Lipton RA, Greenwald RA, Seriff NS. Pneumothorax and bilateral honeycombed lung in Marfan syndrome. Report of a case and review of the pulmonary abnormalities in this disorder. Am Rev Respir Dis 1971;104:924–928.PubMedGoogle Scholar
  484. 484.
    Wood JR, Bellamy D, Child AH, et al. Pulmonary disease in patients with Marfan syndrome. Thorax 1984;39:780–784.PubMedCrossRefGoogle Scholar
  485. 485.
    Sharma BK, Talukdar B, Kapoor R. Cystic lung in Marfan’s syndrome. Thorax 1989;44:978–979.PubMedCrossRefGoogle Scholar
  486. 486.
    Konig P, Boxer R, Morrison J, et al. Bronchial hyperreactivity in children with Marfan syndrome. Pediatr Pulmonol 1991;11:29–36.PubMedCrossRefGoogle Scholar
  487. 487.
    Foster ME, Foster DR. Bronchiectasis and Marfan’s syndrome. Postgrad Med J 1980;56:718–719.PubMedCrossRefGoogle Scholar
  488. 488.
    Disler LJ, Manga P, Barlow JB. Pulmonary arterial aneurysms in Marfan’s syndrome. Int J Cardiol 1988;21:79–82.PubMedCrossRefGoogle Scholar
  489. 489.
    Jain VK, Kumar P, Beniwal OP, et al. Pulmonary tuberculosis in Marfan’s syndrome. J Indian Med Assoc 1986;84:119–120.PubMedGoogle Scholar
  490. 490.
    Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan’s syndrome. Chest 1977;72:672–673.PubMedCrossRefGoogle Scholar
  491. 491.
    Jones JL, Lane JE, Logan JJ, et al. Beals-Hecht syndrome. South Med J 2002;95:753–755.PubMedGoogle Scholar
  492. 492.
    Leung PS, Goppel RL, Ansari A, et al. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61–69.PubMedCrossRefGoogle Scholar
  493. 493.
    Culp KS, Fleming CR, Duffy J, et al. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365–370.PubMedGoogle Scholar
  494. 494.
    Costa C, Sambataro A, Baldi S, et al. Primary biliary cirrhosis: lung involvement. Liver 1995;15:196–201.PubMedGoogle Scholar
  495. 495.
    Nakanuma Y, Ohta G. Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis. Hepatology 1983;3:423–427.PubMedCrossRefGoogle Scholar
  496. 496.
    Maddrey WC. Sarcoidosis and primary biliary cirrhosis. Associated disorders? N Engl J Med 1983;308:588–590.PubMedCrossRefGoogle Scholar
  497. 497.
    Keeffe EB. Sarcoidosis and primary biliary cirrhosis. Literature review and illustrative case. Am J Med 1987;83:977–980.PubMedCrossRefGoogle Scholar
  498. 498.
    Wallaert B, Bonniere P, Prin L, et al. Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms. Chest 1986;90:842–848.PubMedCrossRefGoogle Scholar
  499. 499.
    Spiteri MA, Johnson M, Epstein O, et al. Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis. Gut 1990;31:208–212.PubMedCrossRefGoogle Scholar
  500. 500.
    Wallace JG Jr, Tong MJ, Ueki BH, et al. Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol 1987;9:431–435.PubMedCrossRefGoogle Scholar
  501. 501.
    Golding PL, Smith M, Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med 1973;55:772–782.PubMedCrossRefGoogle Scholar
  502. 502.
    Osaka M, Aramaki T, Okumura H, et al. Primary biliary cirrhosis with fibrosing alveolitis. Gastroenterol Jpn 1988;23:457–460.PubMedGoogle Scholar
  503. 503.
    Yap SH, Schillings PH, Van Tongeren JH. Acute interstitial pneumonia (fibrosing alveolitis) in a patient with primary biliary cirrhosis. Neth J Med 1980;23:111–116.PubMedGoogle Scholar
  504. 504.
    Yoshida EM, Erb SR, Ostrow DN, et al. Pulmonary hypertension associated with primary biliary cirrhosis in the absence of portal hypertension: a case report. Gut 1994;35:280–282.PubMedCrossRefGoogle Scholar
  505. 505.
    Weissman E, Becker NH. Interstitial lung disease in primary biliary cirrhosis. Am J Med Sci 1983;285:21–27.PubMedCrossRefGoogle Scholar
  506. 506.
    Ichikawa Y, Saisho M, Koga H, et al. Lymphocytic alveolitis associated with asymptomatic primary biliary cirrhosis. Kurume Med J 1993;40:59–63.PubMedCrossRefGoogle Scholar
  507. 507.
    Bissuel F, Bizollon T, Dijoud F, et al. Pulmonary hemorrhage and glomerulonephritis in primary biliary cirrhosis. Hepatology 1992;16:1357–1361.PubMedCrossRefGoogle Scholar
  508. 508.
    Strobel ES, Bonnet RB, Werner P, et al. Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosislike lung involvement in a patient with primary biliary cirrhosis. Clin Rheumatol 1998;17:246–249.PubMedCrossRefGoogle Scholar
  509. 509.
    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-1998. A 49-year-old woman with primary biliary cirrhosis, pulmonary opacities, and a pleural effusion. N Engl J Med 1998;338:1293–1301.CrossRefGoogle Scholar
  510. 510.
    Chatte G, Streichenberger N, Boillot O, et al. Lymphocytic bronchitis/bronchiolitis in a patient with primary biliary cirrhosis. Eur Respir J 1995;8:176–179.PubMedCrossRefGoogle Scholar
  511. 511.
    Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjogren’s syndrome in patients with primary biliary cirrhosis. Hepatology 1990;11:730–734.PubMedCrossRefGoogle Scholar
  512. 512.
    Shapiro MS, Dobbins JW, Matthay RA. Pulmonary manifestations of gastrointestinal disease. Clin Chest Med 1989;10:617–643.PubMedGoogle Scholar
  513. 513.
    Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151–183.PubMedGoogle Scholar
  514. 514.
    Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000;15:5–10.PubMedCrossRefGoogle Scholar
  515. 515.
    Kuzela L, Vavrecka A, Prikazska M, et al. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999;46:1714–1719.PubMedGoogle Scholar
  516. 516.
    Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging 1993;8:159–163.PubMedCrossRefGoogle Scholar
  517. 517.
    Butland RJ, Cole P, Citron KM, et al. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med 1981;50:63–75.PubMedGoogle Scholar
  518. 518.
    Wilcox P, Miller R, Miller G, et al. Airway involvement in ulcerative colitis. Chest 1987;92:18–22.PubMedCrossRefGoogle Scholar
  519. 519.
    Moles KW, Varghese G, Hayes JR. Pulmonary involvement in ulcerative colitis. Br J Dis Chest 1988;82:79–83.PubMedCrossRefGoogle Scholar
  520. 520.
    Kraft SC, Earle RH, Roesler M, et al. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454–459.PubMedCrossRefGoogle Scholar
  521. 521.
    Rickli H, Fretz C, Hoffman M, et al. Severe inflammatory upper airway stenosis in ulcerative colitis. Eur Respir J 1994;7:1899–1902.PubMedCrossRefGoogle Scholar
  522. 522.
    Vasishta S, Wood JB, McGinty F. Ulcerative tracheobronchitis years after colectomy for ulcerative colitis. Chest 1994;106:1279–1281.PubMedCrossRefGoogle Scholar
  523. 523.
    Lemann M, Messing B, D’Agay F, et al. Crohn’s disease with respiratory tract involvement. Gut 1987;28:1669–1672.PubMedCrossRefGoogle Scholar
  524. 524.
    Gibb WR, Dhillon DP, Zilkha KJ, et al. Bronchiectasis with ulcerative colitis and myelopathy. Thorax 1987;42:155–156.PubMedCrossRefGoogle Scholar
  525. 525.
    Casey MB, Tazelaar HD, Myers JL, et al. Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 2003;27:213–219.PubMedCrossRefGoogle Scholar
  526. 526.
    Ward H, Fisher KL, Waghray R, et al. Constrictive bronchiolitis and ulcerative colitis. Can Respir J 1999;6:197–200.PubMedGoogle Scholar
  527. 527.
    Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest 1989;95:1342–1344.PubMedCrossRefGoogle Scholar
  528. 528.
    Dawson A, Gibbs AR, Anderson G. An unusual perilobular pattern of pulmonary interstitial fibrosis associated with Crohn’s disease. Histopathology 1993;23:553–556.PubMedCrossRefGoogle Scholar
  529. 529.
    Kayser K, Probst F, Gabius HJ, et al. Are there characteristic alterations in lung tissue associated with Crohn’s disease? Pathol Res Pract 1990;186:485–490.PubMedCrossRefGoogle Scholar
  530. 530.
    Stockley RA. Commentary: bronchiectasis and inflammatory bowel disease. Thorax 1998;53:526–527.PubMedCrossRefGoogle Scholar
  531. 531.
    Calder CJ, Lacy D, Raafat F, et al. Crohn’s disease with pulmonary involvement in a 3 year old boy. Gut 1993;34:1636–1638.PubMedCrossRefGoogle Scholar
  532. 532.
    Puntis JW, Tarlow MJ, Raafat F, et al. Crohn’s disease of the lung. Arch Dis Child 1990;65:1270–1271.PubMedCrossRefGoogle Scholar
  533. 533.
    Shah SM, Texter EC Jr, White HJ. Inflammatory bowel disease associated with granulomatous lung disease: report of a case with endoscopic findings. Gastrointest Endosc 1976;23:98–99.PubMedCrossRefGoogle Scholar
  534. 534.
    Vandenplas O, Casel S, Delos M, et al. Granulomatous bronchiolitis associated with Crohn’s disease. Am J Respir Crit Care Med 1998;158:1676–1679.PubMedCrossRefGoogle Scholar
  535. 535.
    Bentur L, Lachter J, Koren I, et al. Severe pulmonary disease in association with Crohn’s disease in a 13-year-old girl. Pediatr Pulmonol 2000;29:151–154.PubMedCrossRefGoogle Scholar
  536. 536.
    Gionchetti P, Schiavina M, Campieri M, et al. Bronchopulmonary involvement in ulcerative colitis. J Clin Gastroenterol 1990;12:647–650.PubMedCrossRefGoogle Scholar
  537. 537.
    Valletta E, Bertini M, Sette L, et al. Early bronchopulmonary involvement in Crohn disease: a case report. BMC Gastroenterol 2001;1:13.PubMedCrossRefGoogle Scholar
  538. 538.
    Hotermans G, Benard A, Guenanen H, et al. Nongranulomatous interstitial lung disease in Crohn’s disease. Eur Respir J 1996;9:380–382.PubMedCrossRefGoogle Scholar
  539. 539.
    Swinburn CR, Jackson GJ, Cobden I, et al. Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 1988;43:735–736.PubMedCrossRefGoogle Scholar
  540. 540.
    Teague WG, Sutphen JL, Fechner RE. Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood. J Pediatr Gastroenterol Nutr 1985;4:663–667.PubMedCrossRefGoogle Scholar
  541. 541.
    Shneerson JM. Steroid-responsive alveolitis associated with ulcerative colitis. Chest 1992;101:585–586.PubMedCrossRefGoogle Scholar
  542. 542.
    Romas E, Paspaliaris B, d’Apice AJ, et al. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. Aust N Z J Med 1992;22:652–659.PubMedCrossRefGoogle Scholar
  543. 543.
    Stebbing J, Askin F, Fishman E, et al. Pulmonary manifestations of ulcerative colitis mimicking Wegener’s granulomatosis. J Rheumatol 1999;26:1617–1621.PubMedGoogle Scholar
  544. 544.
    Roozendaal C, Kallenberg CG. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin Exp Immunol 1999;116:206–213.PubMedCrossRefGoogle Scholar
  545. 545.
    Dines DE, Green PA, DeRemee RA. Sarcoidosis associated with regional enteritis (Crohn’s disease). Minn Med 1971;54:617–620.PubMedGoogle Scholar
  546. 546.
    Gronhagen-Riska C, Fyhrquist F, Hortling L, et al. Familial occurrence of sarcoidosis and Crohn’s disease. Lancet 1983;1:1287–1288.PubMedCrossRefGoogle Scholar
  547. 547.
    Padilla AJ, Sparberg M. Regional enteritis and sarcoidosis in one patient. A case report. Gastroenterology 1972;63:153–160.PubMedGoogle Scholar
  548. 548.
    Fellermann K, Stahl M, Dahlhoff K, et al. Crohn’s disease and sarcoidosis: systemic granulomatosis? Eur J Gastroenterol Hepatol 1997;9:1121–1124.PubMedCrossRefGoogle Scholar
  549. 549.
    Fries W, Grassi SA, Leone L, et al. Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol 1995;30:1221–1223.PubMedCrossRefGoogle Scholar
  550. 550.
    Gabazza EC, Taguchi O, Yamakami T, et al. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine. Am J Gastroenterol 1992;87:1654–1657.PubMedGoogle Scholar
  551. 551.
    Isenberg JI, Goldstein H, Korn AR, et al. Pulmonary vasculitis—an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med 1968;279:1376–1377.PubMedCrossRefGoogle Scholar
  552. 552.
    Cazzadori A, Braggio P, Bontempini L. Salazopyrin-induced eosinophilic pneumonia. Respiration 1985;47:158–160.PubMedCrossRefGoogle Scholar
  553. 553.
    Williams T, Eidus L, Thomas P. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy. Chest 1982;81:766–768.PubMedCrossRefGoogle Scholar
  554. 554.
    Sviri S, Gafanovich I, Kramer MR, et al. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. J Clin Gastroenterol 1997;24:34–36.PubMedCrossRefGoogle Scholar
  555. 555.
    Tanigawa K, Sugiyama K, Matsuyama H, et al. Mesalazine-induced eosinophilic pneumonia. Respiration 1999;66:69–72.PubMedCrossRefGoogle Scholar
  556. 556.
    Salerno SM, Ormseth EJ, Roth BJ, et al. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener’s granulomatosis. Chest 1996;110:556–559.PubMedCrossRefGoogle Scholar
  557. 557.
    Forrest JA, Shearman DJ. Pulmonary vasculitis and ulcerative colitis. Am J Dig Dis 1975;20:482–486.PubMedCrossRefGoogle Scholar
  558. 558.
    Haralambou G, Teirstein AS, Gil J, et al. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 2001;68:384–388.PubMedGoogle Scholar
  559. 559.
    Beer TW, Edwards CW. Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn’s disease. Thorax 1993;48:1287–1288.PubMedCrossRefGoogle Scholar
  560. 560.
    Meadway J. Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis. Proc R Soc Med 1974;67:324–325.PubMedGoogle Scholar
  561. 561.
    Novotny DA, Rubin RJ, Slezak FA, et al. Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases. Dis Colon Rectum 1992;35:193–196.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Kelly J. Butnor
    • 1
  • Andras Khoor
    • 2
  1. 1.Department of PathologyUniversity of Vermont/Fletcher Allen Health CareBurlingtonUSA
  2. 2.Department of PathologyMayo Clinic JacksonvilleJacksonvilleUSA

Personalised recommendations